ElringKlinger Valuation

Is ZIL2 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ZIL2 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ZIL2 (€4.17) is trading below our estimate of fair value (€27.47)

Significantly Below Fair Value: ZIL2 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ZIL2?

Key metric: As ZIL2 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ZIL2. This is calculated by dividing ZIL2's market cap by their current revenue.
What is ZIL2's PS Ratio?
PS Ratio0.1x
Sales€1.79b
Market Cap€263.89m

Price to Sales Ratio vs Peers

How does ZIL2's PS Ratio compare to its peers?

The above table shows the PS ratio for ZIL2 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.3x
NVM Novem Group
0.5x4.1%€259.0m
ED4 EDAG Engineering Group
0.2x2.7%€173.5m
GMM Grammer
0.03x4.2%€77.5m
SFQ SAF-Holland
0.3x4.9%€635.5m
ZIL2 ElringKlinger
0.1x1.9%€263.9m

Price-To-Sales vs Peers: ZIL2 is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (0.3x).


Price to Sales Ratio vs Industry

How does ZIL2's PS Ratio compare vs other companies in the European Auto Components Industry?

8 CompaniesPrice / SalesEstimated GrowthMarket Cap
ZIL2 0.1xIndustry Avg. 0.3xNo. of Companies16PS00.40.81.21.62+
8 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: ZIL2 is good value based on its Price-To-Sales Ratio (0.1x) compared to the European Auto Components industry average (0.3x).


Price to Sales Ratio vs Fair Ratio

What is ZIL2's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ZIL2 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.1x
Fair PS Ratio0.1x

Price-To-Sales vs Fair Ratio: ZIL2 is expensive based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (0.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ZIL2 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€4.17
€5.70
+36.9%
27.5%€8.50€4.00n/a5
Nov ’25€4.11
€6.38
+55.5%
22.8%€8.50€4.00n/a6
Oct ’25€4.13
€6.42
+55.4%
17.9%€8.00€4.70n/a6
Sep ’25€4.20
€6.83
+62.7%
27.4%€10.50€4.70n/a6
Aug ’25€4.73
€7.65
+61.9%
28.2%€12.00€5.50n/a6
Jul ’25€5.06
€7.65
+51.2%
28.2%€12.00€5.50n/a6
Jun ’25€5.95
€7.65
+28.6%
28.2%€12.00€5.50n/a6
May ’25€6.68
€7.90
+18.3%
30.8%€12.00€5.10n/a6
Apr ’25€6.07
€7.30
+20.3%
39.0%€12.00€4.00n/a6
Mar ’25€5.26
€7.30
+38.8%
39.0%€12.00€4.00n/a6
Feb ’25€5.07
€7.30
+44.0%
39.0%€12.00€4.00n/a6
Jan ’25€5.52
€7.47
+35.3%
37.4%€12.00€4.00n/a6
Dec ’24€5.96
€7.75
+30.1%
35.7%€12.00€4.00€4.106
Nov ’24€5.16
€8.13
+57.6%
39.4%€12.50€4.00€4.116
Oct ’24€5.87
€7.76
+32.2%
35.3%€12.50€5.00€4.135
Sep ’24€5.98
€7.76
+29.9%
35.3%€12.50€5.00€4.205
Aug ’24€7.72
€11.15
+44.4%
22.7%€14.00€8.00€4.735
Jul ’24€8.25
€12.00
+45.5%
19.0%€14.00€8.00€5.065
Jun ’24€8.51
€10.92
+28.3%
29.3%€14.00€5.50€5.956
May ’24€10.17
€10.50
+3.2%
31.9%€14.00€5.50€6.685
Apr ’24€9.40
€10.00
+6.4%
29.6%€14.00€5.50€6.076
Mar ’24€8.78
€9.00
+2.5%
25.6%€12.00€5.50€5.265
Feb ’24€7.86
€9.00
+14.6%
29.6%€13.00€5.50€5.076
Jan ’24€6.96
€9.00
+29.4%
29.6%€13.00€5.50€5.526
Dec ’23€7.55
€9.00
+19.2%
29.6%€13.00€5.50€5.966

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies